DAWN Day One Biopharmaceuticals, Inc.
Healthcare$21.53+0.00%ClosedMarket Cap: $2.22B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
44
Buy/Sell Ratio
0.00
Net Shares
-4,401,678
Shares Acquired
0
Shares Disposed
4,401,678
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Apr 27 | AI Day1 LLC | 10 percent owner | Sell | 12,929,322 | $21.50 | 0 |
| Mon Apr 27 | AI Day1 LLC | 10 percent owner | Sell | 827,586 | $0.00 | 0 |
| Thu Apr 23 | York Charles N II | officer: COO and CFO | Sell | 312,025 | $0.00 | 0 |
| Thu Apr 23 | York Charles N II | officer: COO and CFO | Sell | 162,000 | $8.99 | 0 |
| Thu Apr 23 | VASCONCELLES MICHAEL | officer: Head of Research and Dev. | Sell | 346,000 | $6.64 | 0 |
| Thu Apr 23 | VASCONCELLES MICHAEL | officer: Head of Research and Dev. | Sell | 171,000 | $11.16 | 0 |
| Thu Apr 23 | VASCONCELLES MICHAEL | officer: Head of Research and Dev. | Sell | 106,875 | $0.00 | 0 |
| Thu Apr 23 | VASCONCELLES MICHAEL | officer: Head of Research and Dev. | Sell | 4,397 | $0.00 | 0 |
| Thu Apr 23 | Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 808,285 | $0.00 | 0 |
| Thu Apr 23 | Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 355,000 | $11.16 | 0 |
| Thu Apr 23 | Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 286,000 | $8.99 | 0 |
| Thu Apr 23 | Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 222,188 | $0.00 | 0 |
| Wed Feb 18 | Merendino Lauren | officer: Chief Commercial Officer | Sell | 5,814 | $11.60 | 60,157 |
| Wed Feb 18 | Merendino Lauren | officer: Chief Commercial Officer | Sell | 4,625 | $0.00 | 69,375 |
| Wed Feb 18 | Merendino Lauren | officer: Chief Commercial Officer | Sell | 3,688 | $0.00 | 57,659 |